Pfizer/BioNTech finds Covid vaccine safe and effective for children 12 to 15

Pfizer/BioNTech finds Covid vaccine safe and effective for children 12 to 15

The Guardian

.

.
.
.

Studies show vaccine produces robust antibody responses in school-age children, companies say

The Pfizer and BioNTech pharmaceutical partnership announced on Wednesday that their Covid-19 vaccine was safe, effective and produced robust antibody responses in 12-to 15-year old children, paving the way for them to seek US authorisation within the next few weeks and from regulators in other countries swiftly thereafter.

Related: Germany restricts use of AstraZeneca jab to over-60s

Continue reading…